“…This is in contrast to the positive effects of imipramine in school phobia reported by the senior author (Gittleman- Klein and Klein, 1971) twenty years previously. Another controlled study of low dose (40-75 mg) clomipramine also failed to show efficacy for school phobia (Berney et al, 1981).…”
Drug treatments for psychiatric disorders in children have always been a matter of controversy. During the past two decades psychopharmacologists have made considerable strides in establishing the efficacy and safety of existing drugs. Recent research has also generated new treatments whose practical benefits are yet to be established. This article presents a brief and selective overview of the current state of paediatric psychopharmacology.
“…This is in contrast to the positive effects of imipramine in school phobia reported by the senior author (Gittleman- Klein and Klein, 1971) twenty years previously. Another controlled study of low dose (40-75 mg) clomipramine also failed to show efficacy for school phobia (Berney et al, 1981).…”
Drug treatments for psychiatric disorders in children have always been a matter of controversy. During the past two decades psychopharmacologists have made considerable strides in establishing the efficacy and safety of existing drugs. Recent research has also generated new treatments whose practical benefits are yet to be established. This article presents a brief and selective overview of the current state of paediatric psychopharmacology.
“…Such relationships have been explored from various perspectives, including family-based, 7,8 biological, 9,10 pharmacologic, [11][12][13] and longitudinal approaches. [14][15][16][17][18][19][20][21][22] Only longitudinal research directly quantifies the risk for adult anxiety or depressive disorders faced by adolescents with anxiety or depression.…”
An anxiety or depressive disorder during adolescence confers a strong risk for recurrent anxiety or depressive disorders during early adulthood. Most anxiety and depressive disorders in young adults may be preceded by anxiety or depression in adolescence.
“…The use of imipramine (IMI) seemed judicious because of its possible efficacy on the affective and asthmatic symptomatolo gy. A controlled study has suggested that IMI is effective in the treatment of separation anxiety disorder [4,5]. By the same token, several case series of asthmatic patients have reported on a potential therapeutic effect of tricyclics on asthmatic symptoms [6][7][8], Al though these were noncontrolled studies with multiple méthodologie flaws, similar conclusions were reached in careful animal studies which suggested that tricyclics have bronchiodilatory effects [9,10].…”
Imipramine is an established treatment for anxiety in adults. Some evidence also exists that it may be beneficial in children. Because of the frequent co-occurrence of anxiety and affective symptomatology in asthmatic children, a pilot study was undertaken to obtain clinical observations on the effects of imipramine on symptoms of asthma as well as those of separation anxiety and depression in children suffering from intractable asthma. The pilot trial was terminated because of medical complications after 6 patients participated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.